"The
FDA Fast Track Development Program is a designation of the
United States Food and Drug Administration that accelerates the approval of
investigational new drugs undergoing
clinical trials. Such status is often given to agents that show promise in treating serious, life-threatening medical conditions for which no other drug either exists or works as well."
Might be available "off-label" once approved for pancreas cancer. Almost unheard of remission in pancreatic cancer as single agent with low toxicity. Faster.